Literature DB >> 7033999

Prodrug design.

R E Notari.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7033999     DOI: 10.1016/0163-7258(81)90009-7

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  6 in total

1.  Sympathomimetic bronchodilators: increased selectivity with lung-specific prodrugs.

Authors:  L A Svensson
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

Review 2.  Prodrugs. Do they have advantages in clinical practice?

Authors:  V J Stella; W N Charman; V H Naringrekar
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

3.  Improved delivery through biological membranes. XXXVII. Synthesis and stability of novel redox derivatives of naproxen and indomethacin.

Authors:  M J Phelan; N Bodor
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

Review 4.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

5.  Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.

Authors:  S Genka; J Deutsch; U H Shetty; P L Stahle; V John; I M Lieberburg; F Ali-Osman; S I Rapoport; N H Greig
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

Review 6.  Development of quantitative structure-pharmacokinetic relationships.

Authors:  J M Mayer; H van de Waterbeemd
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.